Table 1.
Characteristics of Included Studies
Study | Country/setting | Comorbid Condition | N | Mean Age (yrs) | Compared Interventions | Mean Dose (mg) | Treatment Length |
---|---|---|---|---|---|---|---|
Pharmacologic Management of Delirium | |||||||
Breitbart16 | USA/Medical Services | AIDS, Medical patients | 30 | 39 | Haloperidol | 1.4 - 2.8 | Up to 6 days |
Chlorpromazine | 36 - 50 | ||||||
Lorazepam | 3 - 4.6 | ||||||
Han17 | Korea/ICU and Medical Services | Medical and surgical patients | 24 | 66 | Haloperidol Risperidone | 1.7 | 7 |
1 | |||||||
Lee18 | South Korea/Medical and Surgical services | Medical and surgical patients | 31 | 62 | Amisulpride Quetiapine | 156 | Up to 7 days |
113 | |||||||
Skrobik19 | Canada/ICU | Medical and surgical patients | 73 | 65 | Haloperidol Olanzapine | 6.5 | 5 days |
4.5 | |||||||
Prevention of Delirium | |||||||
Liptzin20 | USA/Orthopedic Surgery | Elective knee or hip surgery | 80 | 67 | Donepezil placebo | Not reported | 28 days |
Sampson21 | UK/Orthopedic Surgery | Elective hip surgery | 33 | 68 | Donepezil placebo | 5 mg daily | 4 days |
Kalisvaart22 | Netherlands/Orthopedic Surgery | Emergent or elective hip fracture surgery | 430 | 79 | Haloperidol placebo | 0.5 mg three times daily | Minimum 1 day, Maximum 6 days |
Diaz23 | Chile/Orthopedic Surgery | Elective or emergent hip fracture surgery | 81 | 79 | Citicoline Placebo | 400 mg every 8 hours | 4 days |
Pandharipande24 | USA/Medical and Surgical Services | Mechanically ventilated adults | 106 | 60 | Dexmedetomidine Lorazepam | 0.74 mcg/hr 3 mg/hr | Up to 120 hours |
Aizawa25 | Japan/Surgery | Gastric or colon Resection surgery | 42 | 76 | Diazepam, Flunitrazepam, pethidine vs. placebo | 0.1 mg/kg × 1 0.04 mg/kg drip 1 mg/kg drip | 3 days |
Prakanrattana26 | Thailand/Surgery | Cardiac Surgery | 126 | 61 | Risperidone placebo | 1 mg | 1 day |
Leung27 | USA/Neurosurgery | Spine surgery | 21 | 60 | Gabapentin placebo | 900 mg/day | 3 days |
Leung28 | USA/Surgery | Non-cardiac surgery | 228 | 74 | Nitrous oxide + O2 O2 | NR | Procedural administration |
N: Total number of subject in the trial; USA: United States of America; AIDS: Acquired Immunodeficiency Syndrome; ICU: Intensive care unit; NR: Not Reported